Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLD1433 and Conjunctive Melanoma (CM)

<< Previous

Bullboard Posts

Next >>

Comment by patience69on Sep 21, 2021 11:01am

536 Views

Post# 33892131

RE:RE:RE:RE:RE:RE:TLD1433 and Conjunctive Melanoma (CM)

In further discussion of the financial situation it is very frustrating IMO. Every month that goes by the noose around the company"s neck tightens but yet as the trial progresses the value increases. As we run out of $$ the trail gets closer to BTD etc & that should really pop the value. We have to acknowledge that we need financial help some way however we sort of have a moving target. Very interesting I'm sure that management is working very hard on this. As Eog said we have all of those other indications stuck in neutral. Bladder is getting there but even it may hit a wall eventually without further funds. IMO

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland